UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

British journal of cancer, 2009-03, Vol.100 (5), p.684-692

2009

Volltextzugriff (PDF)

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

Annals of oncology, 2009-04, Vol.20 (4), p.615-620

2009

Volltextzugriff (PDF)

A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer

European journal of cancer (1990), 2005-03, Vol.41 (5), p.708-714

2005

Volltextzugriff (PDF)

Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-06, Vol.35 (6), p.397-407

2023

Volltextzugriff (PDF)

A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2751-2756

2006

Volltextzugriff (PDF)

Elucidating the Role of Chest Wall Irradiation in ‘Intermediate-risk’ Breast Cancer: the MRC/EORTC SUPREMO Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-02, Vol.20 (1), p.31-34

2008

Volltextzugriff (PDF)

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

Breast cancer research and treatment, 2017-05, Vol.163 (1), p.63-69

2017

Volltextzugriff (PDF)

A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer — Anglo Celtic VII

Clinical oncology (Royal College of Radiologists (Great Britain)), 2015-08, Vol.27 (8), p.460-464

2015

Volltextzugriff (PDF)

1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019)

European journal of cancer (1990), 2015-09, Vol.51, p.S183-S184

2015

Volltextzugriff (PDF)

Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-02, Vol.25 (2), p.109-116

2013

Volltextzugriff (PDF)

1809 Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study

European journal of cancer (1990), 2015-09, Vol.51, p.S268-S268

2015

Volltextzugriff (PDF)

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)

European journal of cancer (1990), 2006-05, Vol.42 (7), p.882-887

2006

Volltextzugriff (PDF)

Bortezomib docetaxel combination therapy in patients with anthracycline-pretreated advanced metastatic breast cancer: a phase I II dose-escalation study

British journal of cancer, 2008-05, Vol.98 (9), p.1500-1507

2008

Volltextzugriff (PDF)

What are the minimal standards of radiotherapy planning and dosimetry for “hypofractionated” radiotherapy in breast cancer?

Breast (Edinburgh), 2010-06, Vol.19 (3), p.172-175

2010

Volltextzugriff (PDF)

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

European journal of cancer (1990), 2012-03, Vol.48, p.S97-S97

2012

Volltextzugriff (PDF)

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

The lancet oncology, 2015-03, Vol.16 (3), p.266-273

2015

Volltextzugriff (PDF)

200 TACT2 Trial in Early Breast Cancer (EBC): Differential Rates of Amenorrhoea in Premenopausal Women Following Adjuvant Epirubicin (E) or Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF (CRUK/05/019)

European journal of cancer (1990), 2012-03, Vol.48, p.S102-S102

2012

Volltextzugriff (PDF)

Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering Committee

European journal of cancer (1990), 2011, Vol.47, p.2-2

2011

Volltextzugriff (PDF)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet (British edition), 2011-08, Vol.378 (9793), p.771-784

2011

Volltextzugriff (PDF)

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2171-2177

2011

Volltextzugriff (PDF)

Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy

Supportive care in cancer, 2005-12, Vol.13 (12), p.975-986

2005

Volltextzugriff (PDF)

Reducing cardiac dose in post-operative irradiation of breast cancer patients: the relative importance of patient positioning and CT scan planning

British journal of radiology, 1999-10, Vol.72 (862), p.986-993

1999

Volltextzugriff (PDF)

Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer

British journal of cancer, 1998, Vol.77 (3), p.497-500

1998

Volltextzugriff (PDF)

Survey of the suitability of breast-cancer patients for inclusion into adjuvant clinical trials over 11 consecutive weeks in a single new-patient clinic

Clinical oncology (Royal College of Radiologists (Great Britain)), 2004-09, Vol.16 (6), p.440-440

2004

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Englisch
(161)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(75)
Humans
(74)
Female
(59)
Oncology
(45)
Biological And Medical Sciences
(41)
Middle Aged
(35)
Medical Sciences
(33)
Male
(29)
Breast Neoplasms - Drug Therapy
(28)
Adult
(26)
Aged
(24)
Breast Cancer
(24)
Tumors
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Chemotherapy
(20)
Pharmacology. Drug Treatments
(20)
Breast Neoplasms - Pathology
(17)
Hematology, Oncology And Palliative Medicine
(16)
Aged, 80 And Over
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer

A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer

Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity

A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer

Elucidating the Role of Chest Wall Irradiation in ‘Intermediate-risk’ Breast Cancer: the MRC/EORTC SUPREMO Trial

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer — Anglo Celtic VII

1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019)

Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial

1809 Results of the OPTIMA (Optimal Personalized Treatment of early breast cancer usIng Multi-parameter Analysis) prelim study

A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)

Bortezomib docetaxel combination therapy in patients with anthracycline-pretreated advanced metastatic breast cancer: a phase I II dose-escalation study

What are the minimal standards of radiotherapy planning and dosimetry for “hypofractionated” radiotherapy in breast cancer?

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

200 TACT2 Trial in Early Breast Cancer (EBC): Differential Rates of Amenorrhoea in Premenopausal Women Following Adjuvant Epirubicin (E) or Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF (CRUK/05/019)

Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering Committee

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The SOLD Randomized Clinical Trial

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy

Reducing cardiac dose in post-operative irradiation of breast cancer patients: the relative importance of patient positioning and CT scan planning

Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer

Survey of the suitability of breast-cancer patients for inclusion into adjuvant clinical trials over 11 consecutive weeks in a single new-patient clinic

Suchergebnisse filtern